11-824777-C-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_020376.4(PNPLA2):​c.1430C>G​(p.Pro477Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00189 in 1,542,572 control chromosomes in the GnomAD database, including 44 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P477L) has been classified as Benign.

Frequency

Genomes: 𝑓 0.0092 ( 25 hom., cov: 33)
Exomes 𝑓: 0.0011 ( 19 hom. )

Consequence

PNPLA2
NM_020376.4 missense

Scores

1
3
14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.180

Publications

7 publications found
Variant links:
Genes affected
PNPLA2 (HGNC:30802): (patatin like phospholipase domain containing 2) This gene encodes an enzyme which catalyzes the first step in the hydrolysis of triglycerides in adipose tissue. Mutations in this gene are associated with neutral lipid storage disease with myopathy. [provided by RefSeq, Jul 2010]
PNPLA2 Gene-Disease associations (from GenCC):
  • neutral lipid storage myopathy
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, ClinGen, G2P, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004012674).
BP6
Variant 11-824777-C-G is Benign according to our data. Variant chr11-824777-C-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 261234.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00921 (1403/152280) while in subpopulation AFR AF = 0.031 (1290/41564). AF 95% confidence interval is 0.0296. There are 25 homozygotes in GnomAd4. There are 697 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 25 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PNPLA2NM_020376.4 linkc.1430C>G p.Pro477Arg missense_variant Exon 10 of 10 ENST00000336615.9 NP_065109.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PNPLA2ENST00000336615.9 linkc.1430C>G p.Pro477Arg missense_variant Exon 10 of 10 1 NM_020376.4 ENSP00000337701.4

Frequencies

GnomAD3 genomes
AF:
0.00919
AC:
1398
AN:
152164
Hom.:
25
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0310
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00504
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00637
Gnomad NFE
AF:
0.000279
Gnomad OTH
AF:
0.00669
GnomAD2 exomes
AF:
0.00190
AC:
261
AN:
137416
AF XY:
0.00150
show subpopulations
Gnomad AFR exome
AF:
0.0283
Gnomad AMR exome
AF:
0.00181
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000300
Gnomad OTH exome
AF:
0.00171
GnomAD4 exome
AF:
0.00109
AC:
1512
AN:
1390292
Hom.:
19
Cov.:
42
AF XY:
0.000966
AC XY:
664
AN XY:
687018
show subpopulations
African (AFR)
AF:
0.0335
AC:
1067
AN:
31812
American (AMR)
AF:
0.00203
AC:
74
AN:
36516
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25042
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36192
South Asian (SAS)
AF:
0.0000875
AC:
7
AN:
80012
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
34390
Middle Eastern (MID)
AF:
0.00140
AC:
8
AN:
5696
European-Non Finnish (NFE)
AF:
0.000196
AC:
212
AN:
1082522
Other (OTH)
AF:
0.00248
AC:
144
AN:
58110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
80
160
239
319
399
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00921
AC:
1403
AN:
152280
Hom.:
25
Cov.:
33
AF XY:
0.00936
AC XY:
697
AN XY:
74462
show subpopulations
African (AFR)
AF:
0.0310
AC:
1290
AN:
41564
American (AMR)
AF:
0.00503
AC:
77
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00685
AC:
2
AN:
292
European-Non Finnish (NFE)
AF:
0.000279
AC:
19
AN:
67988
Other (OTH)
AF:
0.00662
AC:
14
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
67
135
202
270
337
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000482
Hom.:
0
Bravo
AF:
0.0105
ESP6500AA
AF:
0.00519
AC:
17
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00142
AC:
141

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Neutral lipid storage myopathy Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

not provided Benign:2
Feb 03, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 21170305) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.069
BayesDel_addAF
Benign
-0.59
T
BayesDel_noAF
Benign
-0.60
CADD
Benign
14
DANN
Benign
0.71
DEOGEN2
Uncertain
0.54
D
Eigen
Benign
-0.72
Eigen_PC
Benign
-0.79
FATHMM_MKL
Benign
0.15
N
LIST_S2
Benign
0.40
T
MetaRNN
Benign
0.0040
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.69
N
PhyloP100
0.18
PrimateAI
Uncertain
0.65
T
PROVEAN
Benign
-2.0
N
REVEL
Benign
0.046
Sift
Pathogenic
0.0
D
Sift4G
Uncertain
0.029
D
Polyphen
0.20
B
Vest4
0.042
MVP
0.30
MPC
0.25
ClinPred
0.024
T
GERP RS
2.3
Varity_R
0.046
gMVP
0.24
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142588621; hg19: chr11-824777; COSMIC: COSV60744871; COSMIC: COSV60744871; API